Abstract:Introduction Polycystic ovary syndrome (PCOS) affects 4–20% of women of reproductive age. The contribution of genetic factors to the etiology of PCOS is 79%, and the contribution of the environment, lifestyle and individual history is 21%. It is believed that the increased production of androgens in PCOS is a consequence of dysregulation of various genes involved in the synthesis of steroid hormones, such as CYP11, CYP17 and CYP19. Conflicting data on the association of the CYP17 gene polymorphism (rs743572) with PCOS determined the purpose of this meta-analysis - to study this association in a larger general population in order to determine whether polymorphism in the CYP17 T/C promoter is associated with an increased risk of PCOS. Methods A systematic search was carried out in various databases for articles on the relationship between rs743572 polymorphism of gene CYP17 and PCOS risk published up to May 2021. The articles were analyzed in accordance with the recommendations for systematic reviews and meta-analyzes (PRISMA). The criteria for inclusion of studies in the meta-analysis were: (i) case-control studies with healthy populations as controls; (ii) a study describing the diagnostic criteria for PCOS, sources of cases and controls; (iii) studies of genetic associations showing the frequency of genotypes of the studied polymorphism and PCOS in humans; (iv) sufficient genotype data to calculate odds ratio (OR) and 95% confidence interval (CI). The control HWE was first assessed for each study using the chi-square test (χ2). Meta-analysis was performed using Review Manager version 5.4. Odds ratios (OR) with a 95% confidence interval (CI) were used to assess the strength of the association between the rs743572 polymorphism of gene CYP17 and PCOS. Pooled OR was calculated for dominant (CC + TC vs. TT), recessive (CC vs. TC + TT), and allelic (C vs. T) models, as well as for homozygous (CC vs. TT) and heterozygous (TC vs. TT) models. Results Out of 577 potentially relevant articles, 17 articles were selected for eligibility assessment after excluding irrelevant and duplicate articles. 2283 cases and 2200 controls were evaluated to identify the relationship between the rs743572 polymorphism of the CYP17 gene and PCOS. Carriage of allele C was considered to increase the risk of PCOS. A significant association with PCOS risk was found for rs743572 in the general population using dominant, allelic and heterozygous models: (p = 0.005, OR = 1.41, 95% CI 1.11–1.79; p = 0, 006, OR = 1.28, 95% CI 1.07–1.53; p = 0.01, OR = 1.38, 95% CI 1.07–1.77), respectively. An association between this polymorphism and PCOS risk was not found in the recessive and homozygous models: (p = 0.16, OR = 1.21, 95% CI 0.93–1.58; p = 0, 08, OR = 1.31, 95% CI 0.96–1.78), respectively. Subgroup analysis according to the ethnicity of the participants showed significant associations between Asian and European populations: a higher association was found among Asian populations in the dominant model (p = 0.04, OR = 1.59, 95% CI 1.02–2.48). Conclusions The meta-analysis showed an increased risk of PCOS in carriers of the C allele rs743572, thus, polymorphism rs743572 is a risk factor for PCOS, especially in the Asian population. To determine the genetic risks of PCOS, further research is needed on different haplotypes and their association with PCOS risk.

Genetic association study from North India to analyze association of CYP19A1 and CYP17A1 with polycystic ovary syndrome

Association Analysis of CYP11A1 Variants with Polycystic Ovary Syndrome: a Case-Control Study from North India

The Association Between Polymorphism Of Insr And Polycystic Ovary Syndrome: A Meta-Analysis

Elucidating the Molecular Genetics of Genes CYP19A1, CYP17, and FSHR Variants Association in Polycystic Ovarian Syndrome

Impact of rs2414096 polymorphism of CYP19 gene on susceptibility of polycystic ovary syndrome and hyperandrogenism in Kashmiri women

CYP19 A1 gene polymorphism and polycystic ovarian syndrome

Genomic association of SNPs rs4077582 of CYP11A1 and rs700519 of CYP19A1 genes with polycystic ovarian syndrome

Association of CYP17 gene polymorphism (rs743572) with polycystic ovary syndrome

Association between CYP19 gene SNP rs2414096 Polymorphism and polycystic ovary syndrome in Chinese women

The study of the impact of genetic polymorphism of aromatase (CYP19) enzyme and the susceptibility to polycystic ovary syndrome (575.5)

Association Between Single Nucleotide Polymorphisms (rs1484215 and rs6495096) in CYP11A1 Gene in Iranian Women with Polycystic Ovary Syndrome

The Association of CYP17A1, CYP19A1, and SHBG Gene Polymorphisms in Polycystic Ovary Syndrome Susceptibility: A Systematic Review and Meta-Analysis

[Polymorphism of CYP11A1 Gene in Chinese Patients with Polycystic Ovarian Syndrome].

Pilot study on evaluation and determination of the prevalence of Polycystic Ovarian Syndrome (PCOS) associated gene markers in the South Indian population

Single-nucleotide polymorphism of INS, INSR, IRS1, IRS2, PPAR-G and CAPN10 genes in the pathogenesis of polycystic ovary syndrome

Role of proinflammatory cytokines TNF-α (rs1800629) and IL-6 (rs1800795) in the pathogenesis of polycystic ovarian syndrome in North Indian females

SNP Rs2470152 in CYP19 is Correlated to Aromatase Activity in Chinese Polycystic Ovary Syndrome Patients.

Genetic Polymorphism in the Vitamin D Receptor Gene and 25-Hydroxyvitamin D Serum Levels in East Indian Women with Polycystic Ovary Syndrome

Common polymorphisms in the CYP1A1 and CYP11A1 genes and polycystic ovary syndrome risk: a meta-analysis and meta-regression

Association Analysis Between the Polymorphisms of Hsd17b5 and Hsd17b6 and Risk of Polycystic Ovary Syndrome in Chinese Population

CYP1A1 gene polymorphisms and polycystic ovary syndrome risk: a meta-analysis and meta-regression.